deucravacitinib 6 MG Oral Tablet [Sotyktu]

RxCUI: 2612098
RxNorm name: deucravacitinib 6 MG Oral Tablet [Sotyktu]
Display name: deucravacitinib 6 MG Oral Tablet [Sotyktu]
Full name: deucravacitinib 6 MG Oral Tablet [Sotyktu]
Term type: SBD
Status: DailyMed mapping
Updated: 2026-06-04 23:39:30

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
SOTYKTU	DEUCRAVACITINIB	E.R. Squibb & Sons, L.L.C.	ff4d7258-5068-4cdf-9692-8cae04c3198e	2026-06-30	Warnings, Adverse reactions	Exact identifier rxcui: 2612098

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
ff4d7258-5068-4cdf-9692-8cae04c3198e	SOTYKTU 6 MG Oral Tablet [PSN] · deucravacitinib 6 MG Oral Tablet [Sotyktu] [SBD] · Sotyktu 6 MG Oral Tablet [SY]	3	2	These highlights do not include all the information needed to use SOTYKTU safely and effectively. See full prescribing information for SOTYKTU. SOTYKTU™ (deucravacitinib) tablets, for oral use Initial U.S. Approval: 2022	20260306